Serum complement levels in anti‐N‐methyl‐d‐aspartate receptor encephalitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|25|1|178-184

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.25, Iss.1, 2018-01, pp. : 178-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intrathecal treatment of anti‐N‐Methyl‐d‐aspartate receptor encephalitis in children

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. 1, 2015-01 ,pp. : 95-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti–N‐methyl‐D‐aspartate receptor encephalitis with multiphasic demyelination

By  

ANNALS OF NEUROLOGY, Vol. 76, Iss. 3, 2014-09 ,pp. : 462-464

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis presenting to the emergency department with status epilepticus

By  

Canadian Journal of Emergency Medicine, Vol. 16, Iss. 5, 2014-09 ,pp. : 425-428

Cambridge University Press

Access to resources Recommend Favorite

Deterioration of clinical features of a patient with autism spectrum disorder after anti‐N‐methyl‐D‐aspartate receptor encephalitis

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 8, 2015-08 ,pp. : 507-507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early recognition of anti‐N‐methyl‐D‐aspartate receptor encephalitis in psychiatric patients

By  

ACTA PSYCHIATRICA SCANDINAVICA, Vol. 1-690X, Iss. 4, 2015-10 ,pp. : 312-313

John Wiley & Sons Inc

Access to resources Recommend Favorite